genedrive plc (LON:GDR – Get Free Report) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 1.22 and traded as low as GBX 0.95. genedrive shares last traded at GBX 1, with a volume of 6,861,864 shares changing hands.
genedrive Stock Up 8.0%
The company has a current ratio of 0.99, a quick ratio of 5.52 and a debt-to-equity ratio of -120.48. The stock’s 50-day moving average price is GBX 1.21 and its 200-day moving average price is GBX 1.09. The company has a market cap of £17.26 million, a P/E ratio of -1.36 and a beta of 0.99.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
Further Reading
- Five stocks we like better than genedrive
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
